Global Ibuprofen

Ibuprofen Comprehensive Study by Type (USP, EP), Application (Tablet, Capsule, Suspension, Other), End users (Adults, Children) Players and Region - Global Market Outlook to 2030

Ibuprofen Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 20.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Ibuprofen is an anti-inflammatory drug which helps in releasing the pain including headache, dental pain, menstrual cramps, muscle aches and arthritis. Additionally it relieves from fever, and common cold. Ibuprofen can be consumed by adults and children. This drug has an anti-platelet effect which prevents blood clots. Also, it prevents the production Prostaglandins which is released due to the illness. World health organisation has included ibuprofen in Essential drugs list. Ibuprofen usage for curing various diseases is fueling the market growth. According to AMA Research, the market for Ibuprofen is expected to register a CAGR of 20.3% during the forecast period to 2030. This growth is primarily driven by Increasing Geriatric Population is Fueling the Market of Ibuprofen.

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Supplies sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as BASF (Germany), Albemarle (United States), IOLCP (India), Shandong Xinhua Pharmaceutical Co.,Ltd (China), Dr.Reddy's (India), Juhua Group Corparation (China), Shandong Xinhua Pharmaceutical (China), Granules (India), Strides Shasun (India) and SI Group (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2018, BASF has acquired Bayer. This acquisition will enhance the innovation potential and agricultural solutions
In August 2021,Alkem Laboratories has launched Ibuprofen and Famotidine tablets in the strenght of 800 mg/26.6 mg in the United States, following an approval from the United States

Influencing Trend:
Adoption of Ibuprofen for Treating Mild Symptoms

Market Growth Drivers:
Increasing Geriatric Population is Fueling the Market of Ibuprofen

Challenges:
High Competition Due to the Presence of Major Companies and Lack of Awareness about the Ibuprofen

Restraints:
Longer Approval Process for Drugs May Hamper the Market and Consumption of Ibuprofen is leading to Side Effects

Opportunities:
Growing Number of Online Portals is creating an Opportunity for Ibuprofen Market and Rising Demand among the Consumers

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Ibuprofen Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Ibuprofen Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Ibuprofen players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Ibuprofen Study Sheds Light on
— The Ibuprofen Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Ibuprofen industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Ibuprofen industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • USP
  • EP
By Application
  • Tablet
  • Capsule
  • Suspension
  • Other
By End users
  • Adults
  • Children

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Geriatric Population is Fueling the Market of Ibuprofen
    • 3.3. Market Challenges
      • 3.3.1. High Competition Due to the Presence of Major Companies
      • 3.3.2. Lack of Awareness about the Ibuprofen
    • 3.4. Market Trends
      • 3.4.1. Adoption of Ibuprofen for Treating Mild Symptoms
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ibuprofen, by Type, Application, End users and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Ibuprofen (Value)
      • 5.2.1. Global Ibuprofen by: Type (Value)
        • 5.2.1.1. USP
        • 5.2.1.2. EP
      • 5.2.2. Global Ibuprofen by: Application (Value)
        • 5.2.2.1. Tablet
        • 5.2.2.2. Capsule
        • 5.2.2.3. Suspension
        • 5.2.2.4. Other
      • 5.2.3. Global Ibuprofen by: End users (Value)
        • 5.2.3.1. Adults
        • 5.2.3.2. Children
      • 5.2.4. Global Ibuprofen Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Ibuprofen: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BASF (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Albemarle (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. IOLCP (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Shandong Xinhua Pharmaceutical Co.,Ltd (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dr.Reddy's (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Juhua Group Corparation (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shandong Xinhua Pharmaceutical (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Granules (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Strides Shasun (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. SI Group (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Ibuprofen Sale, by Type, Application, End users and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Ibuprofen (Value)
      • 7.2.1. Global Ibuprofen by: Type (Value)
        • 7.2.1.1. USP
        • 7.2.1.2. EP
      • 7.2.2. Global Ibuprofen by: Application (Value)
        • 7.2.2.1. Tablet
        • 7.2.2.2. Capsule
        • 7.2.2.3. Suspension
        • 7.2.2.4. Other
      • 7.2.3. Global Ibuprofen by: End users (Value)
        • 7.2.3.1. Adults
        • 7.2.3.2. Children
      • 7.2.4. Global Ibuprofen Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ibuprofen: by Type(USD Million)
  • Table 2. Ibuprofen USP , by Region USD Million (2018-2023)
  • Table 3. Ibuprofen EP , by Region USD Million (2018-2023)
  • Table 4. Ibuprofen: by Application(USD Million)
  • Table 5. Ibuprofen Tablet , by Region USD Million (2018-2023)
  • Table 6. Ibuprofen Capsule , by Region USD Million (2018-2023)
  • Table 7. Ibuprofen Suspension , by Region USD Million (2018-2023)
  • Table 8. Ibuprofen Other , by Region USD Million (2018-2023)
  • Table 9. Ibuprofen: by End users(USD Million)
  • Table 10. Ibuprofen Adults , by Region USD Million (2018-2023)
  • Table 11. Ibuprofen Children , by Region USD Million (2018-2023)
  • Table 12. South America Ibuprofen, by Country USD Million (2018-2023)
  • Table 13. South America Ibuprofen, by Type USD Million (2018-2023)
  • Table 14. South America Ibuprofen, by Application USD Million (2018-2023)
  • Table 15. South America Ibuprofen, by End users USD Million (2018-2023)
  • Table 16. Brazil Ibuprofen, by Type USD Million (2018-2023)
  • Table 17. Brazil Ibuprofen, by Application USD Million (2018-2023)
  • Table 18. Brazil Ibuprofen, by End users USD Million (2018-2023)
  • Table 19. Argentina Ibuprofen, by Type USD Million (2018-2023)
  • Table 20. Argentina Ibuprofen, by Application USD Million (2018-2023)
  • Table 21. Argentina Ibuprofen, by End users USD Million (2018-2023)
  • Table 22. Rest of South America Ibuprofen, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Ibuprofen, by Application USD Million (2018-2023)
  • Table 24. Rest of South America Ibuprofen, by End users USD Million (2018-2023)
  • Table 25. Asia Pacific Ibuprofen, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Ibuprofen, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Ibuprofen, by Application USD Million (2018-2023)
  • Table 28. Asia Pacific Ibuprofen, by End users USD Million (2018-2023)
  • Table 29. China Ibuprofen, by Type USD Million (2018-2023)
  • Table 30. China Ibuprofen, by Application USD Million (2018-2023)
  • Table 31. China Ibuprofen, by End users USD Million (2018-2023)
  • Table 32. Japan Ibuprofen, by Type USD Million (2018-2023)
  • Table 33. Japan Ibuprofen, by Application USD Million (2018-2023)
  • Table 34. Japan Ibuprofen, by End users USD Million (2018-2023)
  • Table 35. India Ibuprofen, by Type USD Million (2018-2023)
  • Table 36. India Ibuprofen, by Application USD Million (2018-2023)
  • Table 37. India Ibuprofen, by End users USD Million (2018-2023)
  • Table 38. South Korea Ibuprofen, by Type USD Million (2018-2023)
  • Table 39. South Korea Ibuprofen, by Application USD Million (2018-2023)
  • Table 40. South Korea Ibuprofen, by End users USD Million (2018-2023)
  • Table 41. Taiwan Ibuprofen, by Type USD Million (2018-2023)
  • Table 42. Taiwan Ibuprofen, by Application USD Million (2018-2023)
  • Table 43. Taiwan Ibuprofen, by End users USD Million (2018-2023)
  • Table 44. Australia Ibuprofen, by Type USD Million (2018-2023)
  • Table 45. Australia Ibuprofen, by Application USD Million (2018-2023)
  • Table 46. Australia Ibuprofen, by End users USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Ibuprofen, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Ibuprofen, by Application USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Ibuprofen, by End users USD Million (2018-2023)
  • Table 50. Europe Ibuprofen, by Country USD Million (2018-2023)
  • Table 51. Europe Ibuprofen, by Type USD Million (2018-2023)
  • Table 52. Europe Ibuprofen, by Application USD Million (2018-2023)
  • Table 53. Europe Ibuprofen, by End users USD Million (2018-2023)
  • Table 54. Germany Ibuprofen, by Type USD Million (2018-2023)
  • Table 55. Germany Ibuprofen, by Application USD Million (2018-2023)
  • Table 56. Germany Ibuprofen, by End users USD Million (2018-2023)
  • Table 57. France Ibuprofen, by Type USD Million (2018-2023)
  • Table 58. France Ibuprofen, by Application USD Million (2018-2023)
  • Table 59. France Ibuprofen, by End users USD Million (2018-2023)
  • Table 60. Italy Ibuprofen, by Type USD Million (2018-2023)
  • Table 61. Italy Ibuprofen, by Application USD Million (2018-2023)
  • Table 62. Italy Ibuprofen, by End users USD Million (2018-2023)
  • Table 63. United Kingdom Ibuprofen, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Ibuprofen, by Application USD Million (2018-2023)
  • Table 65. United Kingdom Ibuprofen, by End users USD Million (2018-2023)
  • Table 66. Netherlands Ibuprofen, by Type USD Million (2018-2023)
  • Table 67. Netherlands Ibuprofen, by Application USD Million (2018-2023)
  • Table 68. Netherlands Ibuprofen, by End users USD Million (2018-2023)
  • Table 69. Rest of Europe Ibuprofen, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Ibuprofen, by Application USD Million (2018-2023)
  • Table 71. Rest of Europe Ibuprofen, by End users USD Million (2018-2023)
  • Table 72. MEA Ibuprofen, by Country USD Million (2018-2023)
  • Table 73. MEA Ibuprofen, by Type USD Million (2018-2023)
  • Table 74. MEA Ibuprofen, by Application USD Million (2018-2023)
  • Table 75. MEA Ibuprofen, by End users USD Million (2018-2023)
  • Table 76. Middle East Ibuprofen, by Type USD Million (2018-2023)
  • Table 77. Middle East Ibuprofen, by Application USD Million (2018-2023)
  • Table 78. Middle East Ibuprofen, by End users USD Million (2018-2023)
  • Table 79. Africa Ibuprofen, by Type USD Million (2018-2023)
  • Table 80. Africa Ibuprofen, by Application USD Million (2018-2023)
  • Table 81. Africa Ibuprofen, by End users USD Million (2018-2023)
  • Table 82. North America Ibuprofen, by Country USD Million (2018-2023)
  • Table 83. North America Ibuprofen, by Type USD Million (2018-2023)
  • Table 84. North America Ibuprofen, by Application USD Million (2018-2023)
  • Table 85. North America Ibuprofen, by End users USD Million (2018-2023)
  • Table 86. United States Ibuprofen, by Type USD Million (2018-2023)
  • Table 87. United States Ibuprofen, by Application USD Million (2018-2023)
  • Table 88. United States Ibuprofen, by End users USD Million (2018-2023)
  • Table 89. Canada Ibuprofen, by Type USD Million (2018-2023)
  • Table 90. Canada Ibuprofen, by Application USD Million (2018-2023)
  • Table 91. Canada Ibuprofen, by End users USD Million (2018-2023)
  • Table 92. Mexico Ibuprofen, by Type USD Million (2018-2023)
  • Table 93. Mexico Ibuprofen, by Application USD Million (2018-2023)
  • Table 94. Mexico Ibuprofen, by End users USD Million (2018-2023)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Ibuprofen: by Type(USD Million)
  • Table 106. Ibuprofen USP , by Region USD Million (2025-2030)
  • Table 107. Ibuprofen EP , by Region USD Million (2025-2030)
  • Table 108. Ibuprofen: by Application(USD Million)
  • Table 109. Ibuprofen Tablet , by Region USD Million (2025-2030)
  • Table 110. Ibuprofen Capsule , by Region USD Million (2025-2030)
  • Table 111. Ibuprofen Suspension , by Region USD Million (2025-2030)
  • Table 112. Ibuprofen Other , by Region USD Million (2025-2030)
  • Table 113. Ibuprofen: by End users(USD Million)
  • Table 114. Ibuprofen Adults , by Region USD Million (2025-2030)
  • Table 115. Ibuprofen Children , by Region USD Million (2025-2030)
  • Table 116. South America Ibuprofen, by Country USD Million (2025-2030)
  • Table 117. South America Ibuprofen, by Type USD Million (2025-2030)
  • Table 118. South America Ibuprofen, by Application USD Million (2025-2030)
  • Table 119. South America Ibuprofen, by End users USD Million (2025-2030)
  • Table 120. Brazil Ibuprofen, by Type USD Million (2025-2030)
  • Table 121. Brazil Ibuprofen, by Application USD Million (2025-2030)
  • Table 122. Brazil Ibuprofen, by End users USD Million (2025-2030)
  • Table 123. Argentina Ibuprofen, by Type USD Million (2025-2030)
  • Table 124. Argentina Ibuprofen, by Application USD Million (2025-2030)
  • Table 125. Argentina Ibuprofen, by End users USD Million (2025-2030)
  • Table 126. Rest of South America Ibuprofen, by Type USD Million (2025-2030)
  • Table 127. Rest of South America Ibuprofen, by Application USD Million (2025-2030)
  • Table 128. Rest of South America Ibuprofen, by End users USD Million (2025-2030)
  • Table 129. Asia Pacific Ibuprofen, by Country USD Million (2025-2030)
  • Table 130. Asia Pacific Ibuprofen, by Type USD Million (2025-2030)
  • Table 131. Asia Pacific Ibuprofen, by Application USD Million (2025-2030)
  • Table 132. Asia Pacific Ibuprofen, by End users USD Million (2025-2030)
  • Table 133. China Ibuprofen, by Type USD Million (2025-2030)
  • Table 134. China Ibuprofen, by Application USD Million (2025-2030)
  • Table 135. China Ibuprofen, by End users USD Million (2025-2030)
  • Table 136. Japan Ibuprofen, by Type USD Million (2025-2030)
  • Table 137. Japan Ibuprofen, by Application USD Million (2025-2030)
  • Table 138. Japan Ibuprofen, by End users USD Million (2025-2030)
  • Table 139. India Ibuprofen, by Type USD Million (2025-2030)
  • Table 140. India Ibuprofen, by Application USD Million (2025-2030)
  • Table 141. India Ibuprofen, by End users USD Million (2025-2030)
  • Table 142. South Korea Ibuprofen, by Type USD Million (2025-2030)
  • Table 143. South Korea Ibuprofen, by Application USD Million (2025-2030)
  • Table 144. South Korea Ibuprofen, by End users USD Million (2025-2030)
  • Table 145. Taiwan Ibuprofen, by Type USD Million (2025-2030)
  • Table 146. Taiwan Ibuprofen, by Application USD Million (2025-2030)
  • Table 147. Taiwan Ibuprofen, by End users USD Million (2025-2030)
  • Table 148. Australia Ibuprofen, by Type USD Million (2025-2030)
  • Table 149. Australia Ibuprofen, by Application USD Million (2025-2030)
  • Table 150. Australia Ibuprofen, by End users USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Ibuprofen, by Type USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Ibuprofen, by Application USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Ibuprofen, by End users USD Million (2025-2030)
  • Table 154. Europe Ibuprofen, by Country USD Million (2025-2030)
  • Table 155. Europe Ibuprofen, by Type USD Million (2025-2030)
  • Table 156. Europe Ibuprofen, by Application USD Million (2025-2030)
  • Table 157. Europe Ibuprofen, by End users USD Million (2025-2030)
  • Table 158. Germany Ibuprofen, by Type USD Million (2025-2030)
  • Table 159. Germany Ibuprofen, by Application USD Million (2025-2030)
  • Table 160. Germany Ibuprofen, by End users USD Million (2025-2030)
  • Table 161. France Ibuprofen, by Type USD Million (2025-2030)
  • Table 162. France Ibuprofen, by Application USD Million (2025-2030)
  • Table 163. France Ibuprofen, by End users USD Million (2025-2030)
  • Table 164. Italy Ibuprofen, by Type USD Million (2025-2030)
  • Table 165. Italy Ibuprofen, by Application USD Million (2025-2030)
  • Table 166. Italy Ibuprofen, by End users USD Million (2025-2030)
  • Table 167. United Kingdom Ibuprofen, by Type USD Million (2025-2030)
  • Table 168. United Kingdom Ibuprofen, by Application USD Million (2025-2030)
  • Table 169. United Kingdom Ibuprofen, by End users USD Million (2025-2030)
  • Table 170. Netherlands Ibuprofen, by Type USD Million (2025-2030)
  • Table 171. Netherlands Ibuprofen, by Application USD Million (2025-2030)
  • Table 172. Netherlands Ibuprofen, by End users USD Million (2025-2030)
  • Table 173. Rest of Europe Ibuprofen, by Type USD Million (2025-2030)
  • Table 174. Rest of Europe Ibuprofen, by Application USD Million (2025-2030)
  • Table 175. Rest of Europe Ibuprofen, by End users USD Million (2025-2030)
  • Table 176. MEA Ibuprofen, by Country USD Million (2025-2030)
  • Table 177. MEA Ibuprofen, by Type USD Million (2025-2030)
  • Table 178. MEA Ibuprofen, by Application USD Million (2025-2030)
  • Table 179. MEA Ibuprofen, by End users USD Million (2025-2030)
  • Table 180. Middle East Ibuprofen, by Type USD Million (2025-2030)
  • Table 181. Middle East Ibuprofen, by Application USD Million (2025-2030)
  • Table 182. Middle East Ibuprofen, by End users USD Million (2025-2030)
  • Table 183. Africa Ibuprofen, by Type USD Million (2025-2030)
  • Table 184. Africa Ibuprofen, by Application USD Million (2025-2030)
  • Table 185. Africa Ibuprofen, by End users USD Million (2025-2030)
  • Table 186. North America Ibuprofen, by Country USD Million (2025-2030)
  • Table 187. North America Ibuprofen, by Type USD Million (2025-2030)
  • Table 188. North America Ibuprofen, by Application USD Million (2025-2030)
  • Table 189. North America Ibuprofen, by End users USD Million (2025-2030)
  • Table 190. United States Ibuprofen, by Type USD Million (2025-2030)
  • Table 191. United States Ibuprofen, by Application USD Million (2025-2030)
  • Table 192. United States Ibuprofen, by End users USD Million (2025-2030)
  • Table 193. Canada Ibuprofen, by Type USD Million (2025-2030)
  • Table 194. Canada Ibuprofen, by Application USD Million (2025-2030)
  • Table 195. Canada Ibuprofen, by End users USD Million (2025-2030)
  • Table 196. Mexico Ibuprofen, by Type USD Million (2025-2030)
  • Table 197. Mexico Ibuprofen, by Application USD Million (2025-2030)
  • Table 198. Mexico Ibuprofen, by End users USD Million (2025-2030)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ibuprofen: by Type USD Million (2018-2023)
  • Figure 5. Global Ibuprofen: by Application USD Million (2018-2023)
  • Figure 6. Global Ibuprofen: by End users USD Million (2018-2023)
  • Figure 7. South America Ibuprofen Share (%), by Country
  • Figure 8. Asia Pacific Ibuprofen Share (%), by Country
  • Figure 9. Europe Ibuprofen Share (%), by Country
  • Figure 10. MEA Ibuprofen Share (%), by Country
  • Figure 11. North America Ibuprofen Share (%), by Country
  • Figure 12. Global Ibuprofen share by Players 2023 (%)
  • Figure 13. Global Ibuprofen share by Players (Top 3) 2023(%)
  • Figure 14. Global Ibuprofen share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. BASF (Germany) Revenue, Net Income and Gross profit
  • Figure 17. BASF (Germany) Revenue: by Geography 2023
  • Figure 18. Albemarle (United States) Revenue, Net Income and Gross profit
  • Figure 19. Albemarle (United States) Revenue: by Geography 2023
  • Figure 20. IOLCP (India) Revenue, Net Income and Gross profit
  • Figure 21. IOLCP (India) Revenue: by Geography 2023
  • Figure 22. Shandong Xinhua Pharmaceutical Co.,Ltd (China) Revenue, Net Income and Gross profit
  • Figure 23. Shandong Xinhua Pharmaceutical Co.,Ltd (China) Revenue: by Geography 2023
  • Figure 24. Dr.Reddy's (India) Revenue, Net Income and Gross profit
  • Figure 25. Dr.Reddy's (India) Revenue: by Geography 2023
  • Figure 26. Juhua Group Corparation (China) Revenue, Net Income and Gross profit
  • Figure 27. Juhua Group Corparation (China) Revenue: by Geography 2023
  • Figure 28. Shandong Xinhua Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 29. Shandong Xinhua Pharmaceutical (China) Revenue: by Geography 2023
  • Figure 30. Granules (India) Revenue, Net Income and Gross profit
  • Figure 31. Granules (India) Revenue: by Geography 2023
  • Figure 32. Strides Shasun (India) Revenue, Net Income and Gross profit
  • Figure 33. Strides Shasun (India) Revenue: by Geography 2023
  • Figure 34. SI Group (United States) Revenue, Net Income and Gross profit
  • Figure 35. SI Group (United States) Revenue: by Geography 2023
  • Figure 36. Global Ibuprofen: by Type USD Million (2025-2030)
  • Figure 37. Global Ibuprofen: by Application USD Million (2025-2030)
  • Figure 38. Global Ibuprofen: by End users USD Million (2025-2030)
  • Figure 39. South America Ibuprofen Share (%), by Country
  • Figure 40. Asia Pacific Ibuprofen Share (%), by Country
  • Figure 41. Europe Ibuprofen Share (%), by Country
  • Figure 42. MEA Ibuprofen Share (%), by Country
  • Figure 43. North America Ibuprofen Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BASF (Germany)
  • Albemarle (United States)
  • IOLCP (India)
  • Shandong Xinhua Pharmaceutical Co.,Ltd (China)
  • Dr.Reddy's (India)
  • Juhua Group Corparation (China)
  • Shandong Xinhua Pharmaceutical (China)
  • Granules (India)
  • Strides Shasun (India)
  • SI Group (United States)
Additional players considered in the study are as follows:
Xinhua-Perrigo Pharmaceutical (China) , Zhejiang Hisoar Pharm (China)
Select User Access Type

Key Highlights of Report


Mar 2024 239 Pages 85 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Ibuprofen Quantitative research analysis
Global Ibuprofen Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Ibuprofen Market are BASF (Germany), Albemarle (United States), IOLCP (India), Shandong Xinhua Pharmaceutical Co.,Ltd (China), Dr.Reddy's (India), Juhua Group Corparation (China), Shandong Xinhua Pharmaceutical (China), Granules (India), Strides Shasun (India) and SI Group (United States) etc.
Tablet segment in Global market to hold robust market share owing to "Increasing Geriatric Population is Fueling the Market of Ibuprofen".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Ibuprofen market throughout the forecasted period.

Know More About Global Ibuprofen Report?

Have a Query? Click Here

Other Related Reports

Vitamin D3 Powder Comprehensive Study by Type (Food Grade , Feed Grade ), Application (Food Industry , Pharmaceuticals Industry , Feed Industry, Beverage, Cosmetics, Other Applications), Source (Eggs...
$ 3450
Adhesive Bandages Comprehensive Study by Type (Flexible Fabric Bandage, Cohesive Fixation Bandage), Indication (Wound Management, Edema Control and Pain Management, Orthopedic Support, Others), Distr...
$ 3750
Denture Products Comprehensive Study by Type (Cleansers, Fixatives, Others), End Users (Dental Hospitals & Clinics, Dental Academic & Research Institutes, Laboratories, Others), Distribution Channel ...
$ 3500
Disposable Medical Gloves Comprehensive Study by Type (Latex Gloves, Nitrile Gloves), Application (Hospitals, Research Laboratories), Form (Powdered Form, Powdered-free Form), Distribution Channel (D...
$ 3750
Eye Care Solution Comprehensive Study by Type (Multipurpose Contact Lens Solution, Hydrogen Peroxide-based Solution), Application (Household, Eyecare Center, Clinics), Packaging (60ml, 100ml, 120ml),...
$ 3450
Laparotomy Sponges Comprehensive Study by Type (Radiopaque laparotomy sponge, Traditional laparotomy sponge, RFID or barcode laparotomy sponge), Application (Clinical diagnostic laboratories, Physici...
$ 3750